Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch
Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
Ayush Minister launched month long ayurveda celebration drive of Ministry of Ayush
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide
Subscribe To Our Newsletter & Stay Updated
